In conclusion, we show that serum Lp(a) level was significantly positively associated with the occurrence of DN, indicating that Lp(a) may have the potential as a promising target for the diagnosis and treatment of diabetic nephropathy. This evidence concerns the gene LPA and diabetic kidney disease.